Early research (Phase 1)Study completedNCT04634435
What this trial is testing
Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients
Who this might be right for
Multiple Myeloma
Biohaven Pharmaceuticals, Inc. 7